U.S. Supreme Court: A naturally occurring DNA segment is Not Patentable

In its unanimous decision in the case of Association for Molecular Pathology v. Myriad Genetics, Inc., the United States Supreme Court held: A naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated, but cDNA is patent eligible because it is not naturally occurring.

Contributor